Last reviewed · How we verify
Chronic Myelocytic Leukemia Accelerated Phase
Approved treatments
- Gleevec · M.D. Anderson Cancer Center
- Sprycel · Handa Therap
Sprycel works by blocking the activity of a specific protein called Ephrin type-B receptor 6, which is involved in the growth and survival of cancer cells. - Bosulif · Pfizer
Bosulif blocks the abnormal tyrosine kinase activity in cancer cells, inhibiting their growth and proliferation. - Gleevec · Novartis
Gleevec works by blocking the activity of specific enzymes involved in cancer cell growth and proliferation. - Bosulif · Pfizer
Bosulif works by blocking the activity of a specific enzyme called tyrosine-protein kinase ABL1, which is involved in the growth and survival of cancer cells. - Tasigna · Cipla
Tasigna works by blocking the abnormal Bcr/Abl protein that drives the growth of cancer cells in CML. - Tasigna · XSpray Microparticles
Clinical guidelines
- FDA label — 2L
Dasatinib is indicated for the treatment of adult patients with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib. - FDA label — 2L
Dasatinib is indicated for the treatment of adult patients with chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including imatinib. - FDA label — 2L
Dasatinib is indicated for the treatment of adult patients with Ph+ ALL with resistance or intolerance to prior therapy.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic Myelocytic Leukemia Accelerated Phase patent landscape — cliff calendar, originator estates, attackable patents
- Chronic Myelocytic Leukemia Accelerated Phase treatment landscape brief
- Chronic Myelocytic Leukemia Accelerated Phase treatment updates RSS
Frequently asked questions about Chronic Myelocytic Leukemia Accelerated Phase
What drugs treat Chronic Myelocytic Leukemia Accelerated Phase?
Tracked treatments include Gleevec, Sprycel, Bosulif, Tasigna.
What is the treatment for Chronic Myelocytic Leukemia Accelerated Phase?
Standard treatment for Chronic Myelocytic Leukemia Accelerated Phase includes Gleevec, Sprycel, Bosulif, Tasigna. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Chronic Myelocytic Leukemia Accelerated Phase?
FDA label publishes guidelines for Chronic Myelocytic Leukemia Accelerated Phase. 3 guideline references tracked.
Related
- Treatment landscape: Chronic Myelocytic Leukemia Accelerated Phase patent cliff · Chronic Myelocytic Leukemia Accelerated Phase CI report
- Treatment: Gleevec · M.D. Anderson Cancer Center
- Treatment: Sprycel · Handa Therap
- Treatment: Bosulif · Pfizer
- Treatment: Gleevec · Novartis
- Treatment: Bosulif · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing